EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy

Akiko Wakisaka, Koichi Kimura, Hiroyuki Morita, Koki Nakanishi, Masao Daimon, Masanori Nojima, Hideki Itoh, Atsuhito Takeda, Ruriko Kitao, Tomihiro Imai, Tetsuhiko Ikeda, Takashi Nakajima und 6 weitere

International Heart Journal · 30.03.2024 · 65 (2) · 211-217

DOI: 10.1536/ihj.23-563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Heart Journal, erschienen am 30.03.2024. Verfasst von Akiko Wakisaka und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, NHO Iou National Hospital. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Cardiomyopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneCardiomyopathiesHumansIvabradineRetrospective StudiesDystrophin

Stichwörter der Autor:innen

Dystrophic cardiomyopathyHeart rate reduction

Substanzen

IvabradineDystrophin

Autor:innen und Institutionen

  • Department of Pediatrics, NHO Iou National Hospital.
  • Departments of Laboratory Medicine and Cardiology, The Institute of Medical Science, The University of Tokyo.
  • Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.
  • Department of Cardiology, International University of Health and Welfare Mita Hospital.
  • Center for Translational Research, The Institute of Medical Science, The University of Tokyo.
  • Division of Patient Safety, Hiroshima University Hospital.

Zitieren

APA

Wakisaka, A., Kimura, K., Morita, H., Nakanishi, K., Daimon, M., Nojima, M., Itoh, H., Takeda, A., Kitao, R., Imai, T., Ikeda, T., Nakajima, T., Watanabe, C., Furukawa, T., Ohno, I., Ishida, C., Takeda, N., & Komai, K. (2024). Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy. International Heart Journal, 65(2), 211-217. https://doi.org/10.1536/ihj.23-563

Vancouver

Wakisaka A, Kimura K, Morita H, Nakanishi K, Daimon M, Nojima M, et al. Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy. International Heart Journal. 2024;65(2):211-217. doi:10.1536/ihj.23-563

BibTeX
@article{Wakisaka2024,
  author = {Wakisaka, Akiko and Kimura, Koichi and Morita, Hiroyuki and Nakanishi, Koki and Daimon, Masao and Nojima, Masanori and Itoh, Hideki and Takeda, Atsuhito and Kitao, Ruriko and Imai, Tomihiro and Ikeda, Tetsuhiko and Nakajima, Takashi and Watanabe, Chigusa and Furukawa, Toshihiro and Ohno, Ichiro and Ishida, Chiho and Takeda, Norihiko and Komai, Kiyonobu},
  title = {Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy},
  journal = {International Heart Journal},
  year = {2024},
  volume = {65},
  number = {2},
  pages = {211--217},
  doi = {10.1536/ihj.23-563}
}
Kostenlos starten →